Brian K Alldredge
Professor, Clinical Pharmacy and Neurology
The University of California , USA
Associate Professor, Faculty of Health Science
University of Macau, China
Peter James Little
Head of Pharmacy
University of Queensland, Australia
Journal Impact Factor 1.75*
Submit manuscript at www.scholarscentral.org/submission/clinical-experimental-pharmacology.html or send as an e-mail attachment to the Editorial Office at [email protected]
Table of Contents
About the Journal
The Advantage of publishing in Journal of Clinical & Experimental Pharmacology
- It is an open-access journal which means that your paper is available to anyone around the globe to download for free directly from the Home page.
- We are an e-journal and there are no limits on the number or size of the papers we can publish so, your paper will not be rejected due to lack of space, other aspects.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Journal of Clinical & Experimental Pharmacology (CPECR) team generally complete peer review within 6 weeks. It is therefore very rare to have to wait more than 8 weeks for a final decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
Journal of Clinical & Experimental Pharmacology (CPECR) bridges the gap between medical practice and laboratory science. It explains the way the living organisms react to chemical agents, underlines the importance of registered medical practitioners and prescribed drugs, creates awareness about maximizing the drug effects and minimizing the side effects. The journal provides the best available evidence to support decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by patients.
CPECR is an open access, peer-reviewed, academic journal with a wide range of fields within the discipline and creates a platform for the authors to publish comprehensive and most reliable source of information on discoveries and current developments as original research, methodology papers, short reports, reviews and commentaries in all areas of drug experience on humans.